Search

everythinglearnresearchcommunity

for

Search:↓

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

Ecklonia cava polyphenols help increase human hair growth and reduce hair loss.

The dog with severe hair loss and itching improved after treatment for ehrlichiosis and demodicosis.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.